ReviewEuropean journal of nuclear medicine and molecular imaging2021

The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers.

N J Ashton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.